ALB and hepatocellular carcinoma: A study conducted by Li et al. [134] showed that a high score of pre-treatment serum ALB–BIL grade combined with a pre-treatment serum PLT/LYM ratio independently predicted worse OS and RFS in HCC patients undergoing curative surgical resection.